Khan S, Yetiskul E, Khattar G, Ghada A, Afif S, Khan MWZ, et al. Failure of the PD-1 blocking agent pembrolizumab to benefit a patient with renal squamous cell cancer. EJCRIM [Internet]. 2024 Jun. 27 [cited 2026 Nov. 3];11(7). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4619